CD276 (B7-H3), a member of the B7 superfamily, was shown to be overexpressed in colorectal cancer, pancreatic cancer, diffuse brain glioma, non-small cell lung cancer and head and neck cancers (39–43), and enhanced cancer progression (44, 45). Here, CD276 is linked to pancreatic neoplasm.